Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis

Journal of Neuro-Oncology

Volumn 104, Issue 2, 2011, Pages 545-551

  Lee, Seung Hoon ^a   Kong, Doo Sik ^a   Seol, Ho Joon ^a   Nam, Do Hyun ^a   Lee, Jung Il ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

CNS metastasis; Risk factor; Survival; Ventriculoperitoneal shunt

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN METASTASIS; BRAIN PARENCHYMAL METASTASIS; BRAIN VENTRICLE PERITONEUM SHUNT; BRAIN VENTRICLE PRESSURE; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HYDROCEPHALUS; MALE; MEDICAL RECORD; MENINGEAL METASTASIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIMARY TUMOR; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; HUMANS; HYDROCEPHALUS; KAPLAN-MEIER ESTIMATE; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; RETROSPECTIVE STUDIES; VENTRICULOPERITONEAL SHUNT;

EID: 80052615056     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0512-2     Document Type: Article

References (21)

1. P Kehrli 1999 Epidemiology of brain metastases Neurochirurgie 45 357 363 10717583 1:STN:280:DC%2BD3c7otlyltg%3D%3D (Pubitemid 30158732)
2. U Herrlinger H Forschler W Kuker R Meyermann M Bamberg J Dichgans M Weller 2004 Leptomeningeal metastasis: survival and prognostic factors in 155 patients J Neurol Sci 223 167 178 15337619 10.1016/j.jns.2004.05.008 (Pubitemid 39164359)
3. AM Omuro EC Lallana MH Bilsky LM DeAngelis 2005 Ventriculoperitoneal shunt in patients with leptomeningeal metastasis Neurology 64 1625 1627 15883329 10.1212/01.WNL.0000160396.69050.DC (Pubitemid 40617704)
4. S Taillibert J Hildebrand 2006 Treatment of central nervous system metastases: parenchymal, epidural, and leptomeningeal Curr Opin Oncol 18 637 643 16988587 10.1097/01.cco.0000245323.19411.d7 (Pubitemid 44427640)
5. Oechsle K, Lange-Brock V, Kruell A, Bokemeyer C, de Wit M (2010) Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol (in press)
6. S Taillibert F Laigle-Donadey C Chodkiewicz M Sanson K Hoang-Xuan JY Delattre 2005 Leptomeningeal metastases from solid malignancy: a review J Neurooncol 75 85 99 16215819 10.1007/s11060-004-8101-x (Pubitemid 41548681)
7. MJ Glantz BF Cole L Recht W Akerley P Mills S Saris F Hochberg P Calabresi MJ Egorin 1998 High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16 1561 1567 9552066 1:CAS:528:DyaK1cXis1Ghtr0%3D (Pubitemid 28175781)
8. AB Lassman LE Abrey GD Shah KS Panageas M Begemann MG Malkin JJ Raizer 2006 Systemic high-dose intravenous methotrexate for central nervous system metastases J Neurooncol 78 255 260 16344918 10.1007/s11060-005-9044-6 1:CAS:528:DC%2BD28Xpt1ylt7s%3D (Pubitemid 44018818)
9. MS Berger B Baumeister JR Geyer J Milstein PM Kanev PD LeRoux 1991 The risks of metastases from shunting in children with primary central nervous system tumors J Neurosurg 74 872 877 2033446 10.3171/jns.1991.74.6.0872 1:STN:280:DyaK3M3jslChsQ%3D%3D
10. K Lobotesis JM UK-I JJ Cross JH Gillard NM Antoun 2009 Gliomatosis peritonei associated with a ventriculo-peritoneal shunt Clin Radiol 64 95 99 19070703 10.1016/j.crad.2008.08.015 1:STN:280:DC%2BD1M%2FisFOrug%3D%3D
11. G Zemack B Romner 2000 Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients J Neurosurg 92 941 948 10839253 10.3171/jns.2000.92.6.0941 1:STN:280: DC%2BD3c3ps1SlsQ%3D%3D (Pubitemid 30346511)
12. Chamberlain MC, Glantz M (2006) Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 66:783, author reply 783 (Pubitemid 43739857)
13. LM DeAngelis D Boutros 2005 Leptomeningeal metastasis Cancer Invest 23 145 154 15813508 (Pubitemid 40463913)
14. G Pentheroudakis N Pavlidis 2005 Management of leptomeningeal malignancy Expert Opin Pharmacother 6 1115 1125 15957966 10.1517/14656566.6.7.1115 1:CAS:528:DC%2BD2MXltFeksbo%3D (Pubitemid 40959475)
15. MD Groves 2010 New strategies in the management of leptomeningeal metastases Arch Neurol 67 305 312 20212228 10.1001/archneurol.2010.18
16. MC Chamberlain P Kormanik 1998 Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy Arch Neurol 55 506 512 9561978 10.1001/archneur.55.4.506 1:STN:280:DyaK1c3itVCntw%3D%3D (Pubitemid 28182696)
17. MC Chamberlain PR Kormanik 1997 Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy J Neurooncol 35 55 64 9266441 10.1023/A:1005803918194 1:STN:280:DyaK2svhtFClsQ%3D%3D (Pubitemid 27361846)
18. KA Jaeckle S Phuphanich MJ Bent R Aiken T Batchelor T Campbell D Fulton M Gilbert D Heros L Rogers SJ O'Day W Akerley J Allen S Baidas SZ Gertler HS Greenberg S LaFollette G Lesser W Mason L Recht E Wong MC Chamberlain A Cohn MJ Glantz JC Gutheil B Maria P Moots P New C Russell W Shapiro L Swinnen SB Howell 2001 Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine Br J Cancer 84 157 163 11161370 10.1054/bjoc.2000.1574 1:CAS:528:DC%2BD3MXht1Whu78%3D (Pubitemid 32113439)
19. S Kesari TT Batchelor 2003 Leptomeningeal metastases Neurol Clin 21 25 66 12690644 10.1016/S0733-8619(02)00032-4 (Pubitemid 36169344)
20. FG Barker 2nd 2005 Surgical and radiosurgical management of brain metastases Surg Clin North Am 85 329 345 15833475 10.1016/j.suc.2004.11.003
21. WR Shapiro CE Johanson W Boogerd 2009 Treatment modalities for leptomeningeal metastases Semin Oncol 36 S46 S54 19660683 10.1053/j.seminoncol. 2009.05.006 1:CAS:528:DC%2BD1MXhtFWjtL%2FP